States seek interviews from DOJ’s criminal case against generic pharma

A federal judge in Philadelphia has delayed making a firm decision on whether civil plaintiffs suing generic drugmakers for alleged price-fixing can access confidential interviews from the Department of Justice’s criminal case.

Unlock unlimited access to all Global Competition Review content